Partner? Huh? Myrexis has plenty of cash, and excellent prospects of being seen as a good credit risk in an easy lending environment when they need more cash. Trade half the prospects of a potential blockbuster for cash you don't need? Not a great move.
I'd expect the final 2b results to be presented in a meeting no later than July, which puts us within three months of hearing a topline summary. Probably a little sooner. Later actually suggests an intention to publish in a top-tier journal, which is good (You don't put up with Arnold f'ing Relman for the sake of a finding that'll be forgotten in a year).
You think a company with no products, no revenue, and a management scoffed at by the street, would have "excellent prospects" in this lending environment? I guess that's why we had the subprime debacle. Do you work for Countrywide?
What July? 2011? wrong wrong AGAIN and AGAIN. You have been CONSISTENTLY wrong about the stock. They are still trying to find the RIGHT DOSE for the treatment, so until at least July 2012, there will be nothing to show.